EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Oxygen supplementation and cognitive function in long-COVID

Christine Gagnon, Thomas Vincent, Louis Bherer, Mathieu Gayda, Simon-Olivier Cloutier, Anna Nozza, Marie-Claude Guertin, Patricia Blaise, Isabelle Cloutier, Alan Kamada, Stanislav Glezer iD, André Denault und 1 weitere

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0312735 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift PLOS ONE, 2024. Verfasst von Christine Gagnon und 12 weiteren Autor:innen. Beteiligte Einrichtung: Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Cognition, COVID-19, Cross-Over Studies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Inogen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Patients can experience persistent cognitive complaints and deficits in long-COVID. Inflammation and capillary damage may contribute to symptoms by interfering with tissue oxygenation.

Methods

This was an exploratory pilot crossover study designed to describe the effects of supplemental oxygen (portable oxygen concentrator, POC) on cognitive performance and peripheral and cerebral oxygen saturation at rest and exercise. Participants with long-COVID (n = 21) were randomized 1:1 to: 1) POC (3h/day) for 2 weeks followed by standard of care (Control) for 2 weeks or 2) Control for 2 weeks then POC (3h/day) for 2 weeks, with a 1-week washout. Cognitive assessment (global cognition [Montreal Cognitive Assessment, MoCA], episodic memory [Hopkins], working memory [Digit Span], executive function [Verbal fluency]) was performed at baseline and after each treatment period. Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder-7 were completed. Peripheral and cerebral oxygen saturation were measured at rest and exercise (treadmill) at baseline and after each treatment period. Statistical analyses were descriptive without formal testing.

Results

MoCA scores were similar under POC (26.45±2.31) and Control (26.37±2.85); overall POC-Control difference was -0.090 (95% CI [-1.031, 0.850]). Because of a learning effect, post-hoc analyses were performed for Period 1, where the MoCA score difference was 1.705 [0.140, 3.271]. MoCA subscores suggested better performance with POC for Visuospatial/executive (0.618 [-0.106, 1.342]) and Attention (0.975 [0.207, 1.743]). POC trended to have better scores on Digit Span backward (difference: 0.822 [-0.067, 1.711]) and self-reported depressive symptoms (difference: -1.335 [-3.166, 0.495]). For specific PHQ-9 items, POC tended to have lower (better) scores for Q1 (Little interest/pleasure) and Q7 (Trouble concentrating). Cerebral oxygen saturations at end of exercise showed no difference between POC and Control. Peripheral saturations during exercise were similar under POC and Control (difference: 0.519% [-1.675, 2.714]).

Conclusion

An advantage of POC over Control was observed for global cognition, attention, visuospatial/executive performance and depressive symptoms. Results need to be validated in a larger study.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CognitionCOVID-19Cross-Over StudiesHumansMaleFemaleMiddle AgedOxygenPilot ProjectsAgedOxygen SaturationOxygen Inhalation TherapySARS-CoV-2AdultPost-Acute COVID-19 Syndrome

Substanzen

Oxygen

Autor:innen und Institutionen

  • Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
  • Montreal Health Innovations Coordinating Center (MHICC), Montreal, Quebec, Canada.
  • Inogen, Goleta, California, United States of America.

ORCID-Profile: Stanislav Glezer, Jean-Claude Tardif

Förderung

  • Inogen

Zitieren

APA

Gagnon, C., Vincent, T., Bherer, L., Gayda, M., Cloutier, S. O., Nozza, A., Guertin, M. C., Blaise, P., Cloutier, I., Kamada, A., Glezer, S., Denault, A., & Tardif, J. C. (2024). Oxygen supplementation and cognitive function in long-COVID. PLOS ONE. https://doi.org/10.1371/journal.pone.0312735

Vancouver

Gagnon C, Vincent T, Bherer L, Gayda M, Cloutier SO, Nozza A, et al. Oxygen supplementation and cognitive function in long-COVID. PLOS ONE. 2024. doi:10.1371/journal.pone.0312735

BibTeX
@article{Gagnon2024,
  author = {Gagnon, Christine and Vincent, Thomas and Bherer, Louis and Gayda, Mathieu and Cloutier, Simon-Olivier and Nozza, Anna and Guertin, Marie-Claude and Blaise, Patricia and Cloutier, Isabelle and Kamada, Alan and Glezer, Stanislav and Denault, André and Tardif, Jean-Claude},
  title = {Oxygen supplementation and cognitive function in long-COVID},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0312735}
}
Kostenlos starten →